A Pilot Study of Roadmap 2.0 in Oncology Caregivers and Patients
A Pilot Study of Roadmap 2.0 in Oncology Caregivers and Patients
This study will investigate the use of a mobile health app (Roadmap 2.0) intervention in
 caregivers of patients with cancer. In this study participants will be given the Roadmap 2.0
 app, with a focus on the positive aspects of caregiving (positive activity components), and a
 Fitbit. The primary objective of this pilot study is to test the feasibility and
 acceptability of using the mobile health app.
Health information technology tools may enable caregivers and patients to become more active
 participants in their healthcare.This study is not to provide any treatment, but rather to
 investigate the use of this mobile health technology-mediated intervention (Roadmap 2.0).
Inclusion Criteria:

 1. The caregiver must have an eligible patient (defined in items 5 - 9, below)

 2. The caregiver must be of age ≥18 years.

 3. The caregiver should be comfortable in reading and speaking English and signing
 informed consents.

 4. The caregiver should provide at least 50% of care needs.

 5. An eligible patient is one who identifies the eligible caregiver as their primary
 caregiver (i.e., provides at least 50% of care needs). The caregiver who provides
 consent will be deemed the caregiver who participates in the study. In adolescents who
 are at the age to provide assent, she/he will designate the caregiver who provides
 >50% of their care, and that caregiver will sign the consent document.

 6. An eligible patient is age ≥5 years.

 7. An eligible patient is able to sign informed consent/assent forms.

 8. Patients and caregivers agree to provide informed consent that is in regulatory
 compliance and IRBMED-approved.

 9. The caregiver and patient must have his/her own smartphone or tablet to participate.